Linked Data API

Show Search Form

Search Results

1134907
star this property registered interest false more like this
star this property date less than 2019-06-26more like thismore than 2019-06-26
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading 100,000 Genomes Project more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans his Department has to evaluate the 100,000 Genomes Project. more like this
star this property tabling member constituency Birmingham, Yardley more like this
star this property tabling member printed
Jess Phillips more like this
star this property uin 269788 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-07-05
unstar this property answer text <p>As a Government Major Project, the 100,000 Genomes Project has been under regular review by the Infrastructure and Projects Authority (IPA) which provides independent assurance of the most complex and strategically significant projects across Government. As part of this, the 100,000 Genomes Project has undergone several significant reviews which considered the Project’s delivery, requiring the collation of extensive documentation evidencing the progress of the Project and several days of interviews with key stakeholders. Conclusions of each review were shared across delivery partners to inform successful delivery of the Project.</p><p>The Department, Genomics England and NHS England recognised the importance in embedding robust testing, assessment and evaluation throughout the delivery of the Project to inform the introduction of whole genome sequencing in the National Health Service under the new Genomics Medicine Service.</p><p> </p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-05T11:40:47Zmore like thismore than 2019-07-05T11:40:47Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4370
unstar this property label Biography information for Jess Phillips more like this
1134018
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268506 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134019
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268507 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134020
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268508 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134021
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268509 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134022
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how the Accelerated Access Collaborative plans to balance its focus on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268510 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>There are no restrictions on the type of innovation that can be supported by the Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies, devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In October 2018, the AAC announced it was supporting to increased uptake and use of 12 high performing products, which span seven technology areas, in the National Health Service. Of the seven categories selected for support, two are medicines, four are diagnostic tests, and one is a device.</p><p>Further information about the products the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:06:55.223Zmore like thismore than 2019-07-02T16:06:55.223Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134829
star this property registered interest false more like this
star this property date less than 2019-06-26more like thismore than 2019-06-26
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Antimicrobials: Drug Resistance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what research his Department has undertaken (a) directly, (b) through research councils and (c) with international partners on antimicrobial resistance. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 269618 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2019-07-05
unstar this property answer text <p>The Department is investing over £1 billion a year in health research through the National Institute for Health Research (NIHR). The NIHR supports a wide portfolio of research on antimicrobial resistance (AMR) through various funding streams. In the United Kingdom, investment includes £32 million of capital funding to support AMR research, £19.1 million for AMR research at four NIHR Biomedical Research Centres, and £8.8 million for two NIHR Health Protection Research Units on Healthcare Associated Infections and Antimicrobial Resistance.</p><p>The NIHR also supports research into AMR in low and middle-income countries (LMICs), with official development assistance (ODA) funding through the NIHR Global Health Research programme. Investment includes support for the NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance, and the NIHR Global Health Research Group on Genomic Surveillance of Malaria in West Africa.</p><p>Working through partnerships with other UK funders, the NIHR Global Health Research programme also supports cross-Research Council initiatives including one led by the Medical Research Council for research into AMR in a global context, and another led by the Economic and Social Research Council to expand understanding of how behaviour within and beyond the healthcare system impacts on AMR.</p><p>In addition, the Department has allocated over £50 million of ODA over five years to AMR research through the Global AMR Innovation Fund. This research is delivered through a range of mechanisms and delivery partners, including research councils such as the Biotechnology and Biological Sciences Research Council and Innovate UK, and international partners including the Wellcome Trust, Bill and Melinda Gates Foundation, the United States and German governments, and Canada’s International Development Research Centre.</p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-05T11:34:34.067Zmore like thismore than 2019-07-05T11:34:34.067Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this
1132453
star this property registered interest false more like this
star this property date less than 2019-06-17more like thismore than 2019-06-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Arthritis: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department has taken to (a) ensure patient safety and (b) support pioneering medical research to tackle (i) rheumatoid arthritis and (ii) other inflammatory conditions in the event that the UK leaves the EU without a deal. more like this
star this property tabling member constituency Linlithgow and East Falkirk more like this
star this property tabling member printed
Martyn Day more like this
star this property uin 265579 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-06-20more like thismore than 2019-06-20
unstar this property answer text <p>The Government remains committed to leaving the European Union with a deal. However, as a responsible Government, we must plan for every eventuality, including no deal.</p><p>We have been working closely with partners across the health and care system and industry to ensure the continued health and safety of patients, including ensuring supplies of medicines and medical products, and securing the future of our EU health and care workforce.</p><p>The Department has published EU Exit operational readiness guidance for the health and care system in England outlining actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of a no deal exit scenario.</p><p>We continue to monitor and analyse overall staffing levels across the National Health Service and adult social care, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies following the UK’s exit from the EU.</p><p>The UK has an outstanding track record for research into rheumatoid arthritis and other inflammatory conditions. The Government invests over £1 billion in health research through the National Institute for Health Research (NIHR). This provides direct funding for health research and clinical trials and also the skills, facilities and infrastructure to undertake clinical trials in the health and care service funded by public, charity and industry funders.</p><p>In 2017/18, the NIHR provided £11.7 million funding for research on the inflammatory and immune system (this includes rheumatoid arthritis, connective tissue diseases, autoimmune diseases, allergies and normal development and function of the immune system, as per the UK Clinical Research Collaboration Health Research Classification System, of which £1.2 million was for research on rheumatoid arthritis. In addition, the NIHR Clinical Research Network provides the support to deliver research by public, charity and industry funders in the health and care system.</p><p>The UK and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in pioneering medical research for rheumatoid arthritis and other inflammatory conditions.</p><p>As a responsible Government, we are continuing to prepare for all scenarios. In the event that the UK leaves the EU without a deal at the end of this extension period, the Government has confirmed that the funding commitments made under the guarantee and the extension still stand. Through these commitments, the Government will underwrite funding for all successful competitive eligible UK bids to Horizon 2020 that are submitted before the end of the Programme. This guarantee will apply for the lifetime of projects and will provide funding for UK participation in pioneering Horizon 2020 medical research projects can continue.</p><p> </p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-20T15:36:21.927Zmore like thismore than 2019-06-20T15:36:21.927Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4488
unstar this property label Biography information for Martyn Day more like this
1134249
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Arthritis: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress the NHS has made on research into the (a) causes and (b) potential cures for people with rheumatoid arthritis. more like this
star this property tabling member constituency South Holland and The Deepings more like this
star this property tabling member printed
Sir John Hayes more like this
star this property uin 268364 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
unstar this property answer text <p>Research on health and social care continues to be funded by the Government through the National Institute for Health Research (NIHR).</p><p>The NIHR supports health research into rheumatoid arthritis which benefits National Health Service patients. From 2014/15 to 2018/19, the NIHR funded 42 research programmes and individual awards, including doctoral research fellowships and clinical lectureships, on rheumatoid arthritis, with a total value of £18,558,918.</p><p>The NIHR is funding early translational (experimental medicine) research into new treatments and diagnostics for rheumatoid arthritis through its Biomedical Research Centres (BRCs). This includes significant themes focusing on relevant research at a range of BRCs, such as the inflammatory arthritis theme at the NIHR Birmingham BRC, the immunity, infection and inflammation theme at the NIHR Cambridge BRC, and the musculoskeletal disease theme at the NIHR Newcastle BRC. The NIHR also funds Clinical Research Facilities (CRFs), and in 2017/18 there were dedicated studies into rheumatoid arthritis underway at the NIHR Guy’s and St Thomas’ CRF, the NIHR Nottingham CRF and the NIHR Sheffield CRF, among others.</p><p>Further, the NIHR Joint Translational Research Collaboration (JTRC), established in 2011, relaunched in March 2019 as the UK Musculoskeletal Translational Research Collaboration (UK MSK TRC), a strategic partnership between the NIHR and Versus Arthritis. This brings together Versus Arthritis investment in Experimental Arthritis/Osteoarthritis Treatment Centres, the NIHR JTRC, and all NIHR Biomedical Research Centres and Clinical Research Facilities with expertise in MSK, with the aim of driving cutting edge translational research to improve outcomes for patients. Rheumatoid arthritis is at the forefront of this work.</p>
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-07-02T16:14:42.67Zmore like thismore than 2019-07-02T16:14:42.67Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
350
unstar this property label Biography information for Sir John Hayes more like this
1129836
star this property registered interest false more like this
star this property date less than 2019-06-04more like thismore than 2019-06-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Audiology more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's policies of the recommendation of Action on Hearing Loss in its report on valuing audiology that clinical commissioning groups should be required to collect uniform data in the audiology departments they commission. more like this
star this property tabling member constituency Ealing Central and Acton more like this
star this property tabling member printed
Dr Rupa Huq more like this
star this property uin 260081 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-06-12more like thismore than 2019-06-12
unstar this property answer text <p>Responsibility for audiology data collection rests with individual National Health Service trusts. NHS England’s commissioning framework does however include recommended key performance indicators that can support clinical commissioning groups to incorporate quality management in their contracts. For audiology services this includes recommendations that 90% of service users referred to the service should be assessed within 16 working days of receipt of a referral, and that 90% of service users requiring a hearing aid fitting should be seen within 20 working days of the assessment.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
star this property answering member constituency Gosport remove filter
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-12T10:35:10.047Zmore like thismore than 2019-06-12T10:35:10.047Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4511
unstar this property label Biography information for Dr Rupa Huq more like this